Serum levels of FGF21 are elevated in obese humans [7], and this protein has been suggested as a potential biomarker of Metabolic syndrome (Mets) and Type 2 Diabetes Mellitus (T2DM) [8]. The gene discussed is FGF21; the disease is diabetes mellitus.